VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.58
Tradestie Score
53
Market Cap
$108.92M
Revenue Growth
0.3%
Analyst Upside
+67.8%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.76
|
$170.45M | - | 48 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.52
|
$158.43M | - | 59 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.44
|
$133.50M | - | 54 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.47
|
$110.20M | - | 55 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.65
|
$71.69M | - | 55 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.45
|
$67.94M | - | 54 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$32.77
|
$62.81M | - | 49 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$1.22
|
$46.20M | - | 55 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$11.48
|
$34.77M | - | 57 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$3.20
|
$4.78M | - | 49 | Compare |
More VTGN Analysis
Data updated: Jun 13, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry